These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22467981)

  • 21. Altered circadian rhythm of melatonin concentrations in hypocretin-deficient men.
    Donjacour CE; Kalsbeek A; Overeem S; Lammers GJ; Pévet P; Bothorel B; Pijl H; Aziz NA
    Chronobiol Int; 2012 Apr; 29(3):356-62. PubMed ID: 22390248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypocretins (orexins) and sleep-wake disorders.
    Baumann CR; Bassetti CL
    Lancet Neurol; 2005 Oct; 4(10):673-82. PubMed ID: 16168936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.
    Vankova J; Stepanova I; Jech R; Elleder M; Ling L; Mignot E; Nishino S; Nevsimalova S
    Sleep; 2003 Jun; 26(4):427-30. PubMed ID: 12841368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.
    Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L
    Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Narcolepsy, cataplexy, heart rate, and blood pressure.
    Guilleminault C; Salva MA; Mancuso J; Hayes B
    Sleep; 1986; 9(1 Pt 2):222-6. PubMed ID: 3704446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog.
    Fujiki N; Yoshida Y; Ripley B; Mignot E; Nishino S
    Sleep; 2003 Dec; 26(8):953-9. PubMed ID: 14746374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Narcoleptic episodes in orexin-deficient mice are increased by both attractive and aversive odors.
    Morawska M; Buchi M; Fendt M
    Behav Brain Res; 2011 Sep; 222(2):397-400. PubMed ID: 21510981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients.
    Lodi R; Tonon C; Vignatelli L; Iotti S; Montagna P; Barbiroli B; Plazzi G
    Neurology; 2004 Oct; 63(8):1513-5. PubMed ID: 15505179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy.
    Mishima K; Fujiki N; Yoshida Y; Sakurai T; Honda M; Mignot E; Nishino S
    Sleep; 2008 Aug; 31(8):1119-26. PubMed ID: 18714784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orexin neurons are necessary for the circadian control of REM sleep.
    Kantor S; Mochizuki T; Janisiewicz AM; Clark E; Nishino S; Scammell TE
    Sleep; 2009 Sep; 32(9):1127-34. PubMed ID: 19750917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental divergence of sleep-wake patterns in orexin knockout and wild-type mice.
    Blumberg MS; Coleman CM; Johnson ED; Shaw C
    Eur J Neurosci; 2007 Jan; 25(2):512-8. PubMed ID: 17284193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy.
    Fujiki N; Nishino S
    CNS Neurol Disord Drug Targets; 2007 Feb; 6(1):45-62. PubMed ID: 17305553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
    Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
    J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men.
    Kok SW; Roelfsema F; Overeem S; Lammers GJ; Frölich M; Meinders AE; Pijl H
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E892-9. PubMed ID: 15625087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
    Heier MS; Jansson TS; Gautvik KM
    J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
    Dauvilliers Y; Baumann CR; Carlander B; Bischof M; Blatter T; Lecendreux M; Maly F; Besset A; Touchon J; Billiard M; Tafti M; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1667-73. PubMed ID: 14638887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypocretin and its emerging role as a target for treatment of sleep disorders.
    Cao M; Guilleminault C
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.